Abstract
Objective-To determine whether postmenopausal women with cardiological syndrome X (chest pain and abnormal exercise electrocardiogram despite normal coronary angiography) exhibit disturbances in the full range of proposed components of the putative "insulin resistance syndrome". Patients and methods-20 postmenopausal women with syndrome X and 20 healthy controls each underwent measurement of insulin resistance (by minimal model analysis of the intravenous glucose tolerance test), lipid, lipoprotein, and apolipoprotein concentrations, a range of haemostatic variables, serum uric acid concentration, and centrality of body fat distribution (by dual energy x ray absorptiometry). Results-Women with syndrome X had higher fasting triglyceride concentrations than controls (median: 1-60 v 1*02 mmolIl, P < 0.05). Concentrations of high density lipoprotein cholesterol were lower (1.33 v 1'61 mmol/l, P < 0-05) as were those of the high density lipoprotein apolipoproteins AI and All. Insulin and C peptide responses to the intravenous glucose tolerance test were higher (27.6 v 19*8,uUlmllmin, P < 0 01; 101 v 72 pmolmllmin, P < 0 05, respectively), and insulin sensitivity was lower (1.89 v 3*09 minI,uUIml, P < 0.05). There were, however, no significant differences between other proposed components of the insulin resistance syndrome (blood pressure, glucose tolerance, proportion of central body fat, serum uric acid concentration, and plasminogen activator inhibitor-i activity). Antithrombin The term "syndrome X" was introduced in 1973 by Kemp' to acknowledge uncertainties over the aetiology of angina-like chest pain accompanied by angiographically normal coronary arteries. Conventional diagnostic criteria also include some further evidence of myocardial ischaemia, such as increased myocardial lactate production, reduced coronary sinus oxygen saturation, ST 4 In the present study, we undertook to determine whether insulin resistance syndrome was present in 20 postmenopausal women with syndrome X by comparing them with an age and weight matched group of healthy controls.
Patients and methods

PATIENTS
Women with syndrome X were recruited from a trial of transdermal defined as 'aerobic' for those women who undertook, at least three times a week for 20 min or more, exercise requiring a noticeable increase in breathing rate, 'non-aerobic' for those who described themselves as taking only moderate exercise, and 'none' for those who described themselves as taking no exercise. Time since menopause for women who had undergone a hysterectomy was taken as the time since onset of menopausal symptoms. Numbers of close relatives (parents or siblings) with heart disease or diabetes were recorded. Blood pressure was measured after patients had rested in a semirecumbent position for 15 min. -Indwelling cannulae were inserted into an antecubital vein in each arm, one for glucose administration and the other for sampling. Blood samples were taken for measurement of fasting plasma glucose, insulin, C peptide, serum lipid, and lipoprotein concentrations and factors of the coagulation and fibrinolytic systems. In two cases no samples were taken for coagulation and fibrinolytic assays due to technical problems. An additional sample was taken after 10 min for replicate measurement of fasting plasma glucose, insulin, and C peptide concentrations. An intravenous glucose injection (0 5 g glucose/kg body weight as a 50% (wt/vol) solution of dextrose) was given over 3 min and samples were taken at 3, 5, correlate well with those derived from the glycaemic clamp (r = 0 92).22 Insulin delivery characteristics were evaluated using the minimal model of post-hepatic insulin delivery, which provides measures of fractional insulin elimination rate (inversely related to the plasma insulin half-life), and measures of the responsiveness of first and second phase insulin delivery to glucose (V01 and 02 respectively). A combined model of insulin and C peptide delivery2324 was used to quantify the fractional insulin elimination rate, a measure of the fraction of newly secreted insulin that passes out of the liver, and incremental pancreatic insulin secretion during the IVGTT. Models describing insulin delivery have been evaluated previously. 212325 Differences between the groups were assessed by the Mann-Whitney U test. Relations between individual components of the insulin resistance syndrome were explored using Spearnan's correlation. Statistical analyses employed BMDP statistical software (Los Angeles, California).
Results
The two groups did not differ significantly in age, body mass index, time since menopause or alcohol consumption, nor in the percentage of women with a family history of heart disease or in the number of pregnancies (table  1) . Four women with syndrome X were current smokers compared with none in the control group. The percentages of women who had undergone hysterectomy and who had a family history of diabetes were higher in patients with syndrome X and the proportion of women who took aerobic exercise was lower.
There were no significant differences between women with syndrome X and controls in android to gynoid fat ratio (median: 0 91 v 0 90, respectively), percentage There were no differences between women with syndrome X and controls in fasting plasma concentrations of glucose (median: 5'29 v 5 10 mmol/l, respectively), insulin (0-065 v 0-065 pmol/ml) or C peptide (0 44 v 0 39 pmol/ml). Insulin and C peptide areas of the IVGTT were respectively 39% and 40% higher in patients with syndrome X than in controls and Si was 39% lower (table 3). The Si (min-'.puU-'.ml) 1 controls (table 4) , otherwise there were no significant differences between coagulation and fibrinolytic factors. Repeating these comparisons in analyses in which current smokers (n = 4), women who had undergone hysterectomy (n = 11), or those with a family history of diabetes (n = 6) were excluded did not affect the significance of the differences seen. Exclusion of those taking aerobic exercise (n = 10) reduced some significance levels, but in each of these comparisons the magnitude of the difference between the groups remained the same. For example, median Si was between 36 and 44% lower, triglycerides between 48 and 75% higher, and HDL cholesterol between 13 and 24% lower in the remaining women with syndrome X.
Correlations between potential components of the insulin resistance syndrome were examined in the syndrome X and control groups separately. The magnitude of the correlations in each group were generally similar (results not shown), therefore these relations were evaluated in the study group as a whole. There were significant associations among percentage of android fat, serum triglyceride and HDL cholesterol concentrations, and insulin response to the IVGTT (table 5) . Si also correlated significantly with triglycerides and HDL, although the association with proportion of android fat was of borderline significance (r = -0-29, P = 006). PAI-1 concentrations decreased with increasing Si and HDL cholesterol concentration and rose with increasing percentage of android fat (r = 0-31, P = 0 05). The only significant correlate of serum uric acid concentration was PAI-1 activity. Systolic blood pressure correlated with IVGTT insulin response, but only with borderline significance (r = 0-32, P = 0-07). Otherwise there were no associations between blood pressure and components of the insulin resistance syndrome.
Interrelationships between Si and several other variables were examined. There was a negative association between Si and time since menopause (r = 037, P < 0 05) while no such association was seen with chronological age (r = 0 15, P > 0 3). AT III levels correlated with insulin response to the IVGTT (r = 0 40, P < 001) and Si (r = 0-31, P = 006) and decreasing Si was associated with increasing activity of factor X. (r = -0 33, P < 005). Intercorrelations between components of the insulin resistance syndrome have not been explored in previous studies of cardiological syndrome X. We found significant associations between insulin resistance, increased triglycerides, reduced HDL cholesterol, and proportion of android fat. The inclusion of android fat in this cluster is noteworthy as women with syndrome X did not have an increased proportion of android fat, suggesting that while android fat is an important correlate of metabolic disturbance it is not a factor in the differences seen between healthy postmenopausal women and those with syndrome X. Increased PAI-1 activity was associated with low HDL cholesterol, low Si and an increased proportion of android fat, as would be expected for a component of the insulin resistance syndrome. There were no associations, however, between PAI-1 and triglycerides or the insulin response to the IVGTT. PAI-1 activity was higher in women with syndrome X, but this was not statistically significant: possibly larger group sizes would have rendered this difference significant. Other factors of the coagulation and fibrinolytic systems have not previously been reported in women with syndrome X. The importance of the raised AT III activities in women with syndrome X is difficult to assess: there seems to be a biphasic association between AT III activities and vascular disease, low and high activities being associated with increased risk,29 but there are no reports of increased thrombotic tendency in patients with cardiological syndrome X. The positive associations among AT III, insulin resistance, and increased insulin levels suggest that increased AT III activities might be a candidate for the insulin resistance syndrome. Despite finding no significant differences in the activity of factor X between patients with syndrome X and controls, we found a positive association between Si and factor X activity. We are not aware of any previous reports linking insulin resistance with increased AT III or factor X activities.
A heterogeneous manifestation of disturbances therefore seems to be associated with the insulin resistance syndrome among the women who we studied, with a core of correlations among Si, triglycerides, and HDL cholesterol, probable involvement of android fat levels and PAI-I activities, and no involvement of uric acid or blood pressure. Whether these differences and associations are sufficient for us to conclude that women with cardiological syndrome X manifest the insulin resistance syndrome is arguable. This uncertainty is emphasised by the considerable overlap in individual values between the groups, even in those components of the insulin resistance syndrome that differed significantly. A serious shortcoming in many discussions of the insulin resistance syndrome has been a lack of diagnostic criteria: while correlations and differences in median values may be highly suggestive with regard to groups as a whole, they are insufficient to confer a diagnosis on an individual. Differentials between insulin resistance as it relates to the glucoregulatory, antilipolytic, and haemodynamic effects of insulin may yet undermine the central position ascribed to insulin resistance in the aetiology of correlated metabolic disturbances. Furthermore, it is becoming increasingly apparent that insulin resistance can itself be induced by many of the disturbances that are typical of the syndrome, making it difficult to justify a strict causal chain from insulin resistance to its various manifestations.9
In general, the prognosis of patients with cardiological syndrome X is good,'14 calling into question a role for insulin resistance in the aetiology of coronary artery disease. Follow up studies of patients with syndrome X may have included a substantial proportion who were not insulin resistant. Alternatively, the long-term effects of insulin resistance associated with vascular dysfunction may differ from those of insulin resistance associated with more general, atherogenic metabolic derangement; moreover, a certain minimum complement of metabolic disturbances associated with insulin resistance may be needed to influence long-term health. To resolve these issues, future studies will need to pay particular attention to potential heterogeneity in the insulin resistance syndrome and cardiological syndrome X.
